Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Venous Thromboembolism 2 Prostatic Neoplasms 2 Neoplasms 2 Endometrial Neoplasms 2 Cardiovascular Diseases 2 Venous Thrombosis 1 Stroke 1 Rectal Neoplasms 1 Pulmonary Embolism 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Ischemic Attack, Transient 1 Hypoalphalipoproteinemias 1 Healthy Volunteers 1 Endometrial Hyperplasia 1 Cardiotoxicity 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Atherosclerosis 1

Interventions

Echocardiography 14 Doxorubicin 10 Exercise 8 Electrocardiography 7 Trastuzumab 6 Cyclophosphamide 5 Carvedilol 5 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 dapagliflozin 2 Tablets 2 Social Determinants of Health 2 Silymarin 2 Magnetic Resonance Spectroscopy 2 Ivabradine 2 High-Intensity Interval Training 2 Exercise Test 2 Chemoradiotherapy 2 Blood Specimen Collection 2 Bisoprolol 2 Antineoplastic Agents 2 Anthracyclines 2 sulforaphane 1 schizandrin 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 mitoquinone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cardiotoxicity × Rosuvastatin Calcium × Clear all

NCT07254221 2025-12-10

ROSUBREAST

Shiraz University of Medical Sciences

Phase 4 Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡